3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Sleep Initiation and Maintenance Disorders
19
Breast Neoplasms
14
Neoplasms
12
Anxiety Disorders
7
Prostatic Neoplasms
6
Depression
5
Motor Activity
3
Lymphoma
3
Weight Loss
2
Pain
2
Overweight
2
Ovarian Neoplasms
2
Obesity
2
Multiple Myeloma
2
Lung Neoplasms
2
Glioblastoma
2
Fatigue
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Smoking
1
Small Cell Lung Carcinoma
1
Sleep Wake Disorders
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Sedentary Behavior
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Interventions
Temozolomide
66
Radiotherapy
34
Carboplatin
22
Carmustine
21
Bevacizumab
21
Irinotecan
18
Filgrastim
18
Surgical Procedures, Operative
14
Vincristine
11
Peripheral Blood Stem Cell Transplantation
11
Etoposide
11
Radiation
10
O(6)-benzylguanine
10
Magnetic Resonance Spectroscopy
9
Lomustine
9
Procarbazine
8
Erlotinib Hydrochloride
8
sargramostim
7
IL13-PE38
7
Everolimus
7
Cyclophosphamide
7
Chemotherapy, Adjuvant
7
Thiotepa
6
Radiotherapy, Intensity-Modulated
6
Imatinib Mesylate
6
Granulocyte Colony-Stimulating Factor
6
Drug Therapy
6
Cisplatin
6
temsirolimus
5
antineoplaston AS 2-1
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Astrocytoma
×
Cognitive Behavioral Therapy
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled